Evolutionary history of Staphylococcus aureus influences antibiotic resistance evolution
Current Biology · 2023-08 · 33 (16) · 3389-3397.e5
DOI: 10.1016/j.cub.2023.06.082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Biology, 2023-08. Verfasst von Anaëlle Fait und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark; Department of Environmental Systems Science, ETH…. Hauptthemen laut MEDLINE: Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Antibiotic resistance often confers a fitness cost to the resistant cell and thus raises key questions of how resistance is maintained in the absence of antibiotics and, if lost, whether cells are genetically primed for re-evolving resistance. To address these questions, we have examined vancomycin-intermediate Staphylococcus aureus (VISA) strains that arise during vancomycin therapy. VISA strains harbor a broad spectrum of mutations, and they are known to be unstable both in patients and in the laboratory. Here, we show that loss of resistance in VISA strains is correlated with a fitness increase and is attributed to adaptive mutations, leaving the initial VISA-adaptive mutations intact. Importantly, upon a second exposure to vancomycin, such revertants evolve significantly faster to become VISA, and they reach higher resistance levels than vancomycin-naive cells. Further, we find that sub-lethal concentrations of vancomycin stabilize the VISA phenotype, as do the human β-defensin 3 (hBD-3) and the bacteriocin nisin that both, like vancomycin, bind to the peptidoglycan building block, lipid II. Thus, factors binding lipid II may stabilize VISA both in vivo and in vitro, and in case resistance is lost, mutations remain that predispose to resistance development. These findings may explain why VISA infections often are re-occurring and suggest that previous vancomycin adaptation should be considered a risk factor when deciding on antimicrobial chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark; Department of Environmental Systems Science, ETH Zürich, 8092 Zürich, Switzerland.
- Department of Medical Biochemistry and Microbiology, Uppsala University, 751 23 Uppsala, Sweden.
- Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark. Electronic address: hi@sund.ku.dk.
Zitieren
APA
Fait, A., Andersson, D. I., & Ingmer, H. (2023). Evolutionary history of Staphylococcus aureus influences antibiotic resistance evolution. Current Biology, 33(16), 3389-3397.e5. https://doi.org/10.1016/j.cub.2023.06.082
Vancouver
Fait A, Andersson DI, Ingmer H. Evolutionary history of Staphylococcus aureus influences antibiotic resistance evolution. Current Biology. 2023;33(16):3389-3397.e5. doi:10.1016/j.cub.2023.06.082
BibTeX
@article{Fait2023,
author = {Fait, Anaëlle and Andersson, Dan I and Ingmer, Hanne},
title = {Evolutionary history of Staphylococcus aureus influences antibiotic resistance evolution},
journal = {Current Biology},
year = {2023},
volume = {33},
number = {16},
pages = {3389--3397.e5},
doi = {10.1016/j.cub.2023.06.082}
}
EUVIMED